MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
0.3140
-0.0050
-1.57%
After Hours: 0.3160 +0.002 +0.64% 19:30 09/11 EDT
OPEN
0.3255
PREV CLOSE
0.3190
HIGH
0.3255
LOW
0.2916
VOLUME
410.81K
TURNOVER
--
52 WEEK HIGH
85.40
52 WEEK LOW
0.2916
MARKET CAP
1.62M
P/E (TTM)
-0.0008
1D
5D
1M
3M
1Y
5Y
1D
Jaguar Health Stock Slides Thursday: What's Happening?
Benzinga · 2d ago
Jaguar Health announces all pediatric MVID patients entered extension phase
TipRanks · 2d ago
Jaguar Health Announces All Pediatric Participants In Napo Pharmaceuticals' Crosover Clinical Study Have Entered Extension Phase To Get Doses Of Crofelemer To Treat Microvillus Inclusion Disease
Benzinga · 2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 4d ago
Jaguar Health announces Neonorm Dog availability on Amazon
TipRanks · 4d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 4d ago
Weekly Report: what happened at JAGX last week (0831-0904)?
Weekly Report · 5d ago
Jaguar Health Faces Shareholder Quorum Challenge at Meeting
TipRanks · 09/04 21:34
More
About JAGX
Jaguar Health, Inc. is a commercial stage pharmaceuticals company. The Company is developing prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Its marketed drug Mytesi, (crofelemer 125 mg delayed-release tablets), is a first-in-class oral botanical drug product approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Its Canalevia-CA1, crofelemer delayed-release tablets drug, is an oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea in dogs. It has an exclusive distribution agreement for the sale of Gelclair. It is developing a pipeline of prescription drug product candidates to address unmet needs in gastrointestinal health.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.